Eriochem was born in Argentina and initiated its first global strategic and business development plan in 2000. Over time, it has expanded producing oncology drugs for Latin America, Asia Pacific, Europe and North America, including the United States.
The headquarters, and main production plant, is located in Paraná, province of Entre Ríos, Republic of Argentina, strategic corridor of Mercosur.
It has a presence in Brazil with ERIOCHEM ZENITEC, in the State of São Paulo, Brazil, with offices and a quality control laboratory focused on marketing its products in that country.
It also has facilities in Uruguay, through the company ERIOCHEM SZ located in Canelones. Marketing offices are located there and construction work is beginning on a new Pharmaceutical Plant for Prefilled Syringes according to the highest demands of the world pharmaceutical "state of the art".
The new focus of commercial and institutional development of the company is the United States of America. For this reason, a new company has been created: ERIOCHEM USA. Located in the state of Nevada, it will specialize in the registration and marketing of drugs registered in that country.
The latest achievement was the creation of a new legal entity called ERIOMEX towards the end of 2015. This commercial office is in charge of distribution and marketing in Mexico.
